Status:
COMPLETED
Validation of Indiana's Early Evaluation Hub System
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Purdue University
National Institute of Mental Health (NIMH)
Conditions:
Autism
Eligibility:
All Genders
14-48 years
Phase:
NA
Brief Summary
The investigators' objective is to test an innovative method of autism diagnosis that integrates clinical evaluation and assessment of biobehavioral markers in a large high-risk community-referral sam...
Detailed Description
Determine whether eye-tracking biomarkers can reliably differentiate young children with and without autism in a community referred sample. The study will use a non-invasive remote eye-tracking system...
Eligibility Criteria
Inclusion
- Young children ages 14-48 months seen at an EE hub and referred for a comprehensive autism evaluation.
- Children must have English-speaking caregivers. Children must have a legal guardian that is able to provide consent.
Exclusion
- Child is younger than 14 months or older than 48 months. Child's caregiver(s) is/are not English-speaking.
Key Trial Info
Start Date :
June 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2022
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT06586788
Start Date
June 7 2019
End Date
September 23 2022
Last Update
October 31 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Health Network
Anderson, Indiana, United States, 46011
2
Margaret Mary Health Pediatrics
Batesville, Indiana, United States, 47006
3
Riley Hospital for Children
Indianapolis, Indiana, United States, 46202
4
Meridian Health Pediatrics
Muncie, Indiana, United States, 47304